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2SUMMARY
Here we report the results from a genome-wide linkage scan to identify genes and chromosomal
regions that influence quantitative immune response traits, using multi-case leprosy and
tuberculosis families from north-eastern Brazil. Total plasma IgE, antigen-specific IgG to
Mycobacterium leprae soluble antigen (MLSA), M. tuberculosis soluble antigen (MTSA) and M.
tuberculosis purified protein derivative (PPD), and antigen-specific lymphocyte proliferation
(stimulation index or SI) and interferon-  (IFN-  ) release to MLSA and PPD, were measured in
16 tuberculosis (184 individuals) and 21 leprosy (177 individuals) families. The individuals were
genotyped at 382 autosomal microsatellite markers across the genome. The adjusted
immune-response phenotypes were analysed using a variety of variance components and
regression-based methods. These analyses highlighted a number of practical issues and problems
with regard to implementation of the methods, and, interestingly, differences were observed
between several standard statistical and genetic analysis packages used. From this we determined
that, for this set of traits in these pedigrees, significant  values for linkage using variance
components analysis, supported by significance using the Visscher-Hopper modification of the
Haseman-Elston method, provided the most compelling evidence for linkage. Using these
criteria, linkage ( 
	
	fffi ) was seen for total plasma IgE on chromosome 2; IgG
to MLSA on chromosomes 8, 17 and 21; IgG to PPD on chromosome 12; SI to PPD on
chromosome 1; IFN-  to MLSA on chromosomes 6, 7, 10, 12 and 14; and IFN-  to PPD on
chromosomes 1, 16 and 19.
3INTRODUCTION
A variety of methods have been proposed for quantitative trait linkage analysis in pedigrees. Two
of the most popular approaches are variance components methods (Amos 1994; Almasy &
Blangero 1998) and regression-based methods (Feingold 2002). Although variance components
methods are applicable to arbitrary pedigree structures and are generally more powerful than
regression-based methods when applied to normally distributed traits in unselected samples, these
methods can be quite sensitive to departures from normality and to selection on the basis of trait
value (Feingold 2002). For this reason, many prefer to use regression-based methods that are
generally more robust to selection and distributional issues. The well known Haseman-Elston
(H-E) method for sib-pairs regresses the squared trait difference on the estimated proportion of
alleles shared identical by descent (IBD) at a marker locus (Haseman & Elston 1972). Recently,
several modifications have been proposed to this method, to improve its power. These have
included methods that incorporate additional information from the mean-corrected trait sum
squared (Drigalenko 1998; Elston et al. 2000; Xu et al. 2000; Forrest 2001; Sham & Purcell
2001; Visscher & Hopper 2001; Shete et al. 2003), methods that apply to family structures other
than sibships (Putter et al. 2002; Sham et al. 2002; Chen et al. 2004), methods that generalise the
assumption made on the residual error distribution (Barber et al. 2004) and methods that can be
used for selected samples by regressing the observed IBD sharing on some function of the trait
values, rather than the other way round (Sham et al. 2002; Holmans 2002; Cordell et al. 2003;
Lebrec et al. 2004).
A number of papers have compared the power of the different approaches using data
simulated under various simplifying assumptions (Elston et al. 2000; Xu et al. 2000; Forrest
42001; Visscher and Hopper 2001; Wang and Huang 2002; Sham et al. 2002; T.Cuenco et al.
2003; Yu et al. 2004). The general finding has been that variance components methods, and
regression methods that use a weighted combination of mean-corrected trait sum and the trait
difference, are more powerful than methods that are based on an equally-weighted combination or
based solely on the trait difference. What is perhaps less well studied, is how the different
methods perform in analysis of real data. Real data is often much messier than simulated data,
and raises issues of robustness and interpretability of conflicting results from different methods.
We conducted a variance components analysis and used a variety of traditional (Haseman &
Elston 1972) and new (Xu et al. 2000; Visscher & Hopper 2001; Holmans 2002; Sham et al.
2002; Barber et al. 2004) regression methods to analyse data from a genome scan conducted on
families collected as part of the Belem Family Study (Blackwell et al. 1997). These families were
originally ascertained on the presence of leprosy or tuberculosis, and linkage analyses for these
disease traits have previously been reported (Miller et al. 2004). In addition to disease
phenotypes, these families were assayed for a number of quantitative measures of immune
response, specifically eight quantitative traits corresponding to total plasma IgE, antigen-specific
IgG to Mycobacterium leprae soluble antigen (MLSA), M. tuberculosis soluble antigen (MTSA)
and M. tuberculosis purified protein derivative (PPD), and antigen-specific memory T-cell
responses measured as lymphocyte proliferation (stimulation index or SI) and interferon- fl
(IFN- fl ) release to MLSA and PPD. The purpose of this present study was to evaluate variance
components and regression-based methods to identify regions of the genome that contain
quantitative trait loci that influence these immune response traits using the data from the
genome-wide linkage scan (Miller et al. 2004). Although comparison of the different methods in
a single, real data set (in which the ‘true’ linkages are not yet known) does not provide the same
degree of method comparison as a simulation study, it is of interest to examine the results to see
5whether they are consistent with those expected in the light of the previously conducted
simulation studies, and to use them to draw some general conclusions.
Note that a list of abbreviations used in this paper can be found in Table 1.
METHODS
Ascertainment of families and genotyping
Families used in this study included 16 multicase tuberculosis (184 individuals) and 21 multicase
leprosy (177 individuals) pedigrees that had been genotyped at 382 autosomal microsatellite
markers across the genome as reported previously (Miller et al. 2004). Family sizes ranged from
7 to 22 individuals (with on average 12.76 individuals) and consisted of 2, 3 or 4 generations in
the distributions 37.8%, 54.1% and 8.1% respectively. Depending on phenotype, a maximum of
687 sib pairs were available (genotyped and phenotyped) for analysis. The families were
ascertained through medical records at local Ministerio de Sanidad Health Centers in Bele`m,
Para, Brazil, and were collected during the period 1991-1993. The study was performed with
approval of the ethical review committee of the Institute Evandro Chagas, Bele`m, Para, Brazil.
The age range of family members used in the study was 2 to 86 years old. As in previous studies
(Fine et al. 1989), it proved unreliable to ascertain M. bovis bacillus Calmette-Gue´rin (BCG)
vaccination status on the basis of a BCG scar for the individuals used in the study who were, in
any case, mostly born prior to the implementation of routine neonatal BCG vaccination in 1985.
6Measurement of quantitative immune response traits
Undiluted blood collected by venepuncture into heparin was separated over Ficoll-hypaque in the
laboratory in Brazil. Plasma from the top of the Ficoll-hypaque gradient was collected and stored
in aliquots at -80 ffi "! C for later detection by enzyme-linked immunosorbant assays (ELISA) of
total serum IgE using commercially available mouse anti-human IgE monoclonal antibody pairs
(clones G7-18 and G7-26; Pharmingen, San Diego, California, USA) or antigen-specific IgG to
MLSA, MTSA or PPD as previously described (Sharples et al. 1994). Lymphocytes from the
Buffy coat were plated into 96-well plates, stimulated with MLSA or PPD at 10 # g/ml, and 100 # l
supernatant harvested for IFN- $ measurements at day 6. Quantitative IFN- $ ELISAs were carried
using commercially available mouse anti-human IFN- $ antibody pairs (clones NIB42 and 4S.B3;
Pharmingen). Lymphocyte proliferation was measured either by addition of bromodeoxyuridine
(BrdUrd) or tritiated thymidine ( % H-thymidine) to the cultures at day 6, and cells harvested the
following day. For BrdUrd assays an ELISA was performed as described (Huong et al. 1991). For
% H-thymidine assays, counts were measured using a scintillation counter. Assays were performed
in triplicate. In both cases, stimulation indices (SI) were determined by dividing mean values for
wells with antigen by mean values for the no antigen control wells. Proliferative responses were
measured in 149 individuals using BrdUrd and 212 individuals using % H-thymidine incorporation.
MLSA (http://www.cvmbs.colostate.edu/mip/leprosy/cytosol fraction.html) and MTSA
(http://www.cvmbs.colostate.edu/microbiology/tb/top.htm) cytosolic fractions used in the IgG
ELISAs were prepared at Colorado State University under NIH contracts NO1-A1-25469 and
NO1-A1-40091, respectively. MLSA for lymphocyte assays was an armadillo-derived M. leprae
sonicate prepared according to WHO guidelines (WHO, 1980) and supplied by the National
Institute for Medical Research at Mill Hill, UK. PPD from M. tuberculosis was prepared
7(Magnusson & Bentzon 1958) at the Statens Serum Institut, Copenhagen, Denmark.
Data cleaning and preliminary analyses
The genotype data at each locus was checked for Mendelian inconsistencies using the program
PedCheck (O’Connell & Weeks 1998). Genetic relationships between family members were
checked using the the relationship-estimation program PREST (McPeek & Sun 2000). This
program performs statistical tests using genome scan data to determine whether the pattern of
allele sharing by each pair of relatives is consistent with the relationship indicated by the
pedigree. The PREST analysis led to the omission of 11 individuals (from 4 families) and the two
smaller arms of the small families L 48 and TB 13, in which relationship errors could not be
resolved, from the entire set of families.
Preliminary investigation of the quantitative immune response trait data showed one extreme
outlier (possibly a recording error) for all of the antibody responses. Antibody responses for this
individual were therefore set to missing. The quantitative traits were normalised by using a
natural logarithm transformation. Although this did not produce perfectly normal distributions
(Figure 1), the log transformation seemed to give the best fit, and was the most intuitive (also the
transformation used by Zhang (2003) for IgE concentrations). To account for the two different
methods used to measure lymphocyte proliferation, two new traits for MLSA and PPD were
created combining the results from the different measurement methods. This was achieved by
standardising the normalised traits (so that they all had mean 0 and variance 1) and then
combining the data from all individuals for each of MLSA and PPD to create two new traits,
called ‘lnSIMLSA’ and ‘lnSIPPD’. All eight quantitative traits were adjusted for sex and age
across all the Bele`m individuals. A further four individuals who had outlying observations for one
of the traits had the outlying trait values set to missing. Previous studies show that lepromatous
8leprosy patients acquire extraordinarily high MLSA-specific antibody titres (Hasan et al. 1989)
while their MLSA-specific cellular responses (proliferation and IFN- & ) become secondarily
suppressed (Godal et al. 1971; Weir et al. 1999). For this reason, all MLSA responses (antibody,
lymphocyte proliferation and IFN- & ) for all lepromatous leprosy individuals were also set to
missing. Since this change in immune response is specific to M. leprae (Godal et al. 1971),
MTSA and PPD responses were included for lepromatous leprosy patients. Henceforth, the
antibody responses will be denoted ‘IgGMLSA’, ‘IgGMTSA’, ‘IgGPPD’ and ‘TotalIgE’. The
stimulation indices of lymphocyte proliferation to MLSA and PPD will be denoted ‘SIMLSA’
and ‘SIPPD’, and the IFN- & responses to MLSA and PPD will be denoted ‘gMLSAc’ and
‘gPPDc’. All eight resulting traits have been log-transformed and adjusted for age and sex. After
these adjustments no distributional differences (with regard to the quantitative traits) were
observed between diseased and unaffected individuals. This fact simplifies the analysis by
allowing us to use all individuals in the variance components or regression-based analyses
regardless of disease status. An analysis of variance indicated that variation in the adjusted traits
could be significantly accounted for by family designation, suggesting a familial (potentially
genetic) component to these traits. This was confirmed by estimates of heritability obtained from
the program MERLIN (Abecasis et al. 2002) which estimated heritabilities for the log
transformed, adjusted traits of 0.20 (IgGMLSA), 0.15 (IgGMTSA), 0.13 (IgGPPD), 0.46
(TotalIgE), 0.49 (SIMLSA), 0.80 (SIPPD), 0.74 (gMLSAc) and 0.91 (gPPDc).
The three antigens MLSA, MTSA and PPD are crude preparations from related species of
Mycobacterium and are therefore likely to show some cross-reactivity. In support of this, we
investigated the correlation structure between the eight traits (see Table 2) and observed some
evidence of correlations between IgGMLSA, IgGMTSA and IgGPPD (correlation coefficients
0.36–0.45), and stronger evidence for correlations between SIMLSA and SIPPD (correlation
9coefficient = 0.6) and between gMLSAc and gPPDc (correlation coefficient = 0.66). This is
consistent with the observation that patients and unaffected family members from TB families
made an equivalent range of responses to MLSA as members of leprosy families, and conversely
that patients and family members from leprosy families made equivalent ranges of responses to
MTSA and PPD as members of TB families. However, although leprosy and tuberculosis patients
were never observed together in the same family/household, all families come from the same
regions of Belem City in which the distribution of leprosy and tuberculosis disease overlaps.
Hence, we cannot discount community contact as the basis to MLSA responses in TB families,
and MTSA and PPD responses in leprosy families.
Linkage analyses
Linkage analysis was performed for the eight quantitative traits using the genome scan data. The
families had originally been ascertained and analysed on the basis of the disease traits and so no
power calculation with regard to analysis of the the quantitative traits had previously been
performed. Using simulation techniques, we performed a retrospective power calculation with
regard to analysis of the quantitative traits, assuming the same number of families and family
structure and similar missing data pattern as seen in the real data. We assumed that the trait was
determined by a single dialleleic quantitative trait locus completely linked to a typed marker locus
with 10 equifrequent alleles. We estimated the power of the variance components approach in our
families to be 57%, 93% and 100% for detection of loci of heritability 0.3, 0.5 and 0.7
respectively (at p ' 0.01). Lower power was seen with regression-based analysis using the
approach of Visscher and Hopper (2001) (powers 38%, 79% and 97% respectively) and even
lower power with the original H-E approach (powers 13%, 46% and 81% respectively). These
families therefore provide reasonable power for nominal detection of loci that account for
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heritabilities of 0.5 and above. The families would not be expected to give high power for
detection at genome-wide significance levels, or for detection of loci with low heritabilites.
With the real data, each trait was analysed separately in order to detect genetic regions linked
to specific traits, rather than using multivariate approaches such as those described by Marlow et
al. (2003) or those implemented in the programs ACT (Amos 1994; Amos et al. 1996) and
MENDEL (Lange et al. 2001). Multivariate analysis of more than 3 or 4 traits simultaneously is
computationally and analytically complex, and produces problems in interpretation unless all
traits are believed to pertain to a common, underlying, unobserved phenotype. Individual analysis
of all 8 traits does, however, raise an issue of multiple testing. All significance levels quoted here
correspond to the specific null hypothesis being tested and have not, therefore, been corrected to
account for the 8 traits tested or for genome-wide significance. A conservative correction for the 8
traits would be a Bonferroni correction, but this does not allow for the correlation between traits.
A rough estimate of the number of independent traits was obtained by looking at the eigenvalues
of the phenotypic correlation matrix given in Table 2. The effective number of traits ( eff (Nyholt
2004) was 7.58, indicating low levels of trait correlation. A more precise estimate was obtained
by considering the eigenvalues of the genetic correlation matrix which was calculated in SOLAR
(Almasy & Blangero 1998) using a bivariate variance component analysis (Martin et al. 2003). In
this case the effective number of traits was 6.48, again showing that the majority of the traits are
independent and supporting the analysis of the traits individually.
Variance components analysis was carried out in MENDEL Version 5.5.2 (Lange et al.
2001) with IBD estimation for larger pedigrees (for which exact calculations are not possible)
carried out via Monte Carlo Markov Chain techniques in SIMWALK (Sobel & Lange 1996;
Sobel et al. 2001). Regression-based analyses as described in Haseman & Elston (1972), Xu et
al. (2000), Visscher & Hopper (2001) and Barber et al. (2004) were carried out manually in the
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statistical programming package STATA, using IBD estimates for sibling pairs obtained from the
programs MERLIN (Abecasis et al. 2002) and (for larger pedigrees) SIMWALK. Correlation
between sibling pairs from the same pedigree was corrected for by use of the empirical robust
Huber-White sandwich variance estimator (Huber 1967; White 1982). We also carried out
analysis using two methods that perform the regression of IBD sharing on traits, rather than the
other way round. We used the method of Holmans (2002) for linkage analysis with covariates,
using as a covariate the sib-pair trait difference squared (with robust Huber-White variance
estimation) as implemented in the STATA program IBDREG. Although not originally designed
for linkage analysis of quantitative traits, it has been suggested (Cordell et al. 2003) that the
method of Holmans (2002) might be applicable in this context. We also carried out analyses using
the method of Sham et al. (2002) as implemented in the program MERLIN-REGRESS. For these
analyses, two large pedigrees for which computations would be prohibitively time consuming
were dropped by the MERLIN-REGRESS program. We do not expect the removal of these
families to make much difference to the overall results, since the results from the variance
components analyses are virtually identical regardless of whether or not these pedigrees are
included. The method of Sham et al. (2002) implemented in MERLIN-REGRESS requires prior
estimates of mean, variance and heritability of a trait, and these were obtained from an initial
variance components analysis in MERLIN.
Following the linkage analysis, we observed several regions showing high significance
levels. In order to assess the accuracy of these significance levels, we calculated the empirical
significance in these regions using a permutation procedure. The adjusted and transformed traits
were randomly permuted, either across all individuals or within families, and the test statistic was
recalculated for each permutation replicate. In this way we generated an empirical distribution of
significance values to which the observed significance level could be compared.
12
RESULTS
Results from the variance components analyses are shown in Figure 2. Results from the
regression-based analyses using the original H-E and Visscher & Hopper (2001) (V-H) methods)
are shown in Figure 3. Results from an initial analysis with the Xu et al. (2000) method, before
removal of outlying trait values, showed slightly strange behavior whereby at some positions the
test statistic could not be calculated owing to a negative variance estimate. Following removal of
outliers, results from the Xu et al. (2000) method were found to be virtually identical to those
from the V-H method: since the V-H is considerably simpler to compute (requiring no calculation
of the correlation between estimated regression coefficients from separate regressions of trait
difference squared and mean-corrected trait sum squared), we display only the V-H results.
Figure 4 shows the results from the MERLIN-REGRESS analysis using the method of Sham et
al. (2002).
Since variance components analysis is expected to be the most powerful procedure, we use
this as our starting point and follow up the results in these regions where variance components
analysis gave p )+*,*.- using the more robust, regression-based procedures. The results from the
regression-based procedures do not provide independent supportive evidence for linkage since
they are expected to correlate with the variance components results. However, support of a
variance components peak using the more robust regression-based methods would suggest that
the peak is not simply due to the sensitivity of the variance components method to distributional
assumptions.
Table 3 shows all the variance components peaks with p )+*,*.- , plus those peaks obtained
using the different regression-based methods that lie no more than 15cM to either side of a
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variance components peak. A number of regions showed significance in both the variance
components analysis and in one or more of the regression analyses: regions in which there was a
variance components peak supported by a V-H peak will be considered of particular interest, and
are shown in bold. The traditional H-E analysis gave relatively few significant results, perhaps
because of the decreased power expected with this approach. Interestingly, MERLIN-REGRESS
gave a large number of significant results, and a comparison of Figures 2 and 4 shows that this is
not just in regions that showed significance in the variance components analysis. Although it is
hoped (Sham et al. 2002) that the method implemented in MERLIN-REGRESS will show power
close to that of a variance components analysis, it is not expected that MERLIN-REGRESS will
have greater power than a variance components approach, particularly in an essentially
unselected sample. Although Sham et al. (2004) showed that the method implemented in
MERLIN-REGRESS gave test statistics that were systematically larger than those from variance
components analysis, it was shown by Yu et al. (2004) that this did not translate to an increase in
power. Indeed, standard statistical considerations would suggest that likelihood-based variance
components analysis under the correct model (i.e. if the conditions of multivariate normality and
random ascertainment are met) should be the more powerful approach. The large number of
significant results with MERLIN-REGRESS therefore suggest that this method may be producing
inflated significance (under-estimating the / value) in places. We had hoped to check this using a
permutation procedure in order to generate empirical / values calculated under the null
hypothesis of no linkage. (A similar procedure is applied below to calculate the empirical
significance of the regression-based methods implemented using STATA). Unfortunately, it was
not possible to conduct a permutation procedure for the MERLIN-REGRESS analysis owing to
the fact that the MERLIN-REGRESS analysis was extremely slow (with MERLIN-REGRESS
taking approximately 13 times the time of a MERLIN variance components analysis, or 31 hours
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to analyse a single chromosome). This observation is consistent with results reported by Yu et al.
(2004) who found that MERLIN-REGRESS consumed a large amount of CPU time in
comparison to other methods, when the sibship size was large or the pedigree complex. To
analyse the required 1000 or 10,000 permutation replicates in MERLIN-REGRESS would
therefore have been prohibitively time-consuming. One of the advantages of regression-based
approaches over variance components analysis is that they are generally quicker to implement,
lending themselves to application of simulation or permutation procedures. This advantage,
however, does not appear to apply to MERLIN-REGRESS when analysing extended pedigrees,
perhaps because of the requirement to calculate not just IBD sharing estimates for all pairs of
relatives in a pedigree, but also the variances and covariances of the IBD sharing estimates
between different relative pairs (Sham et al. 2002), potentially a very large number of
comparisons.
The method proposed by Sham et al. (2002) and implemented in MERLIN-REGRESS
involves prior calculation of trait mean, variance and heritability. Although Sham et al. (2002)
found their method relatively robust to misspecifications of these parameters, it is possible that
parameter misspecification could account for an inflation in Type 1 error resulting in an inflated
number of significant results as found here. Alternatively, such results could be attributable to the
relatively small number of pedigrees and/or unusual distributional properties of the traits (Sham et
al. 2002). Given the relatively novel nature of the method and the computational difficulties in
evaluating empirical significance levels, for the time being we would recommend caution in
interpretation of results from MERLIN-REGRESS.
The variance components analysis is expected to be the most powerful of the approaches
considered. However, it may not be robust to departures from normality such as are seen in the
tails of the trait distribution for several of the traits (notably TotalIgE and gPPDc) in Figure 1. We
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therefore focus our attention primarily on regions that were found to be significant in the variance
components analysis and in which the significance was also supported by the more robust V-H
regression approach. Using this strategy, evidence for linkage was seen for total plasma IgE on
chromosome 2 (0214353ff3ff6 ); for IgG to MLSA on chromosomes 8 (02173.53fi398 ), 17 (0214353ff3fi3ff: )
and 21 (0;143.5<3ff3.= ); for IgG to PPD on chromosome 12 (0;143.5<3ff3ff: ); for SI to PPD on
chromosome 1 (0214353ff3fi: ); for IFN- > to PPD on chromosomes 1 (0;17353ff3fi398 ), 16 (0;17353ff3fi? )
and 19 (0;143.5<3ff3ff? ); and for IFN- > to MLSA on chromosomes 6, 7, 10, 12 and 14 (0@3.5<3.= ), see
Table 3.
Results from the regression methods of Barber et al. (2004) and Holmans (2002) (applied to
quantitative traits according to the suggestion of Cordell et al. 2003), were found to be broadly
similar to the other regression-based methods (original H-E and V-H) in terms of the positions of
linkage peaks. However we did find a number of regions where the Barber et al. (2004) and
Holmans/Cordell methods showed much higher significance than the other regression-based
methods. This phenomenon had previously been observed by Cordell et al. (2003) when applying
the method of Holmans (2002) to quantitative traits in this way. An example of six regions/traits
where this occurs is shown in Figure 5. These also include a region on chromosome 1 where the
V-H method gave very high significance (0;1A=ff58CB=3.D
E ) for gPPDc, although this was F 20cM
away from the variance components peak (see Table 3 and Figures 2 and 3). In order to assess
whether these higher significance levels were, in fact, accurate, we calculated approximate
empirical significance in these regions using a permutation procedure. The adjusted and
transformed traits were randomly permuted, either across all individuals or within families.
Permutation of traits across all individuals does not account for residual familial correlations (due
to other genetic or environmental factors) although it should give correct significance levels in the
case where no residual familial correlations exist. Permuting within families provides an
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approximate adjustment for residual familial correlation, although the exact correlation structure,
which depends on pedigree structure, is not maintained. Shete et al. (2003) proposed a two-stage
procedure in which first allele sharing matrices are permuted among sibships of equal size, and
then the allele sharing vectors from the first stage are permuted among the pairs within each
sibship. However, this procedure is not directly applicable in this case since we do not have
sibship data but rather pedigrees of many varying sizes and structures. A permutation procedure
that accounted for pedigree structure would be complicated to implement with a data set of this
complexity, and in any case would be likely to generate relatively few different permutation
configurations.
Table 4 shows the results of the permutation tests. The positions at which the permutations
were calculated are a selection of those at which there were clear differences between at least two
of the regression based methods, or where at least one method gave a highly significant G value.
The results of the permutation tests suggest that the Holmans/Cordell and Barber et al. (2004)
methods are slightly under-estimating the G values in places, whereas the original H-E, V-H and
Xu et al. (2000) methods provide generally reliable estimates of the G value, except perhaps in
regions of very high significance. The reason for this is not entirely clear: it may be that the
methods of Holmans/Cordell and Barber et al. (2004) are more sensitive to certain aspects of the
trait or IBD distribution, or to the fact that we are applying these methods to extended pedigrees
rather than to sib-pairs as originally suggested. In any case, it seems as if care should be taken
when using these methods, and in particular the evaluation of empirical significance levels via
simulation or permutation procedures may be warranted.
In order to check our implementation of the regression-based methods in STATA, we
compared some of our results with those obtained using alternative software, for those methods
for which alternative software was available. Specifically, we compared the results from the
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original H-E method with those obtained using the programs GENEHUNTER (Kruglyak &
Lander 1995; Kruglyak et al. 1996), XWXW (Xu et al. 2000) and the SIBPAL module of
S.A.G.E. (2002), and we compared our results from the weighted (unified) H-E method of Xu et
al. (2000) with those obtained using XWXW (Xu et al. 2000) and S.A.G.E. Interestingly,
although the overall pattern of results was similar, we found that the different programs gave
different results on a number of occasions, even when apparently implementing the same method.
In order to investigate this further, we created two simplified test data sets consisting of 30 (test
data set 1) and 100 (test data set 2) fully-informative randomly ascertained independent sib-pairs
genotyped at a single marker. Use of fully-informative families should remove any difference
between the programs with regards to the treatment of uncertain IBD sharing, and use of
independent sib-pairs (one per family) should remove the issue of non-independence between
pairs from the same pedigree. The results from analysis using the original H-E method are shown
in Table 5. In both test data sets, all of the methods agree on the regression coefficient. The
problems appear to rise in the calculation of the test statistic from the regression coefficient and
its standard error. In the case where the empirical robust Huber-White sandwich variance
estimator was not used, both STATA and S.A.G.E. agree. When robust variance estimates are
used, S.A.G.E. and STATA also agree, however this is only after adjusting for the scaling that
STATA applies to the robust variance estimates. If H is the number of clusters, I is the number of
observations and J is the number of parameters in the model then, for linear regression models the
robust variance matrix is multiplied by K
KMLON
P+Q
LON
Q
L
R (corresponding to 30/28 and 100/98 for the test
data sets). Without adjusting for this scaling, STATA gives a more conservative result. XWXW
claims to implement the classical Haseman-Elston test which would not normally use a robust
variance estimate (particularly in this case where the sib-pairs are, in fact independent), however
the test statistic from XWXW is actually the same as that from STATA and S.A.G.E. with robust
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variance estimates. XWXW also uses a normal approximation to the t-distribution and the
resulting S value is the same as that from S.A.G.E. or STATA when the t-statistic is compared to a
normal distribution. GENEHUNTER gives the most significant results for both data sets and,
considering the simplicity of the simple Haseman-Elston method, it is interesting that the results
from GENEHUNTER (without robust variance estimates, using the unweighted pairs option) do
not match those from either S.A.G.E or STATA for reasons that we have so far been unable to
determine.
For the weighted (unified) H-E method of Xu et al. (2000), we also found differences
between the method as implemented in different programs. Following Shete et al. (2003), the Xu
et al. (2000) method was implemented in SIBPAL (S.A.G.E. 2002) using the weighting option
W2, the robust variance estimator and the independence working matrix options. Robust variance
estimates were used in STATA, scaling the resulting variances as before. The results obtained
from all three programs were different (see Table 6). Although similar, it is disconcerting that the
results are not identical. Unfortunately, the reasons for the observed differences in even these
simple scenarios remain unclear.
DISCUSSION
Here we have reported the results from a genome-wide linkage scan to identify genes and
chromosomal regions that influence a variety of quantitative immune response traits. In carrying
out our analysis, we took the opportunity to perform an empirical comparison between the
bewildering number of regression-based methods for quantitative trait linkage analysis that have
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recently been proposed. Interestingly, we found that some of the methods that were theoretically
the most appealing (in particular the methods of Xu et al. (2000) and Sham et al. (2002)), were
hardest to implement and often less interpretable than the simpler original H-E method (Haseman
& Elston 1972) or the extension by Visscher & Hopper (2001). We also found surprising
differences between several software packages that implemented the various H-E methods, some
of which could be attributed to slightly different treatment of non-independent pairs and/or
methods of variance estimation. Although these differences would be unlikely to cause major
differences in overall results, we nevertheless think it important to alert researchers to the
potential differences between, and assumptions made by, the different programs. In particular,
care should be taken with regards to the desired treatment of non-independent pairs, and whether
use of an empirical robust sandwich variance estimator is warranted.
For the types of pedigrees and the immune response traits analysed here, we concluded that
the most compelling evidence for linkage was obtained by first determining regions of linkage
using variance components analysis, and only accepting those regions supported by the more
robust Visscher & Hopper (2001) extension of the H-E regression-based method. Using these
criteria, we found evidence for linkage of quantitative immune response traits to a number of
chromosomal regions. Interestingly, there was little or no overlap between the regions of
significance highlighted by the eight different traits, suggesting that these traits, although
correlated, may be under independent genetic control. It was of interest too that we did not
replicate the previously reported linkage for total IgE responses on chromosome 5q23.3 which
has been observed in the Amish (Marsh et al. 1994) and The Netherlands (Xu et al. 1995). This
may relate to assay differences between laboratories, and the fact that this quantitative trait
showed the greatest departure from a normal distribution in our study and was associated with
two of the regions that showed the greatest variation between different genetic statistical methods.
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A data set of similar size and scope as ours was used by Iyengar et al. (2004) to detect a
major locus contributing to quantitative age-related macular degeneration (ARMD)
(T;U4VCWXY[Z\ ), as well as several more modest linkage signals. Although none of the regions in
our study showed genome-wide significance, the results provide a first stage in the search for loci
that may influence immune response. In particular, annotations of the human genome in the
public domain (we used NCBI 35 assembly at http://www.ensembl.org/Homo sapiens/) afford us
the opportunity to identify specific genes of potential interest under these peaks of linkage. In so
doing we determined that the peaks of linkage for IFN- ] to PPD on chromosome 1, IFN- ] to
MLSA on chromosome 6, and IgG to MLSA on chromosome 17 all map close to known immune
response gene clusters. Specifically, the peak of linkage for IFN- ] to PPD on chromosome 1q23.3
lies between D1S484 to D1S878 at positions 157.9 to 162.6 Mb which coincides with genes
(FCGR3A, FCGR2A, FCER1G) encoding Fc fragments for IgG and IgE, and a cluster of genes
(SLAM2/4/5, SLAMF3/F6/F1/F7) that encode natural killer cell, T cell or B cell activation
markers or receptors. The peak for IFN- ] to MLSA on chromosome 6p21.2 lies near D6S1610 at
position 39.3, ^ 6 Mb distal to HLA class II genes. This is consistent with previous studies
demonstrating a role for HLA class II and III genes on regulating susceptibility to leprosy in this
study population in Brazil (Shaw et al. 2001). The peak for IgG to MLSA on chromosome 17q21
lies at D17S787, 6 Mb distal to the peak of linkage for susceptibility to leprosy per se reported
earlier (Jamieson et al. 2004). In that study we found evidence for a cluster of genes across the
chromosome region 17q11-q21 controlling susceptibility to tuberculosis and leprosy in this
Brazilian sample that coincided with a large cluster of known immune response genes including
genes encoding chemokines and chemokine receptors, as well as transcription factors STAT3 and
STAT5A/B. None of the other regions identified for antigen-specific responses matched any of the
regions previously identified in analysis of the genome scan data for the disease phenotypes of
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tuberculosis and leprosy per se (Miller et al. 2004).
Amongst the regions of linkage that we observe that fall outside known clusters of immune
response genes, the second region on chromosome 6 at 6q27 controlling IFN- _ to MLSA is of
particular interest. The peaks of linkage for variance components and Visscher-Hopper H-E
analysis lie between D6S264 at position 166.6 Mb and D6S446 at 170.4 Mb. D6S264 lies ` 3 Mb
distal to the Parkinson’s disease gene PARK2 and co-regulated PACRG gene recently shown to
play a major role in susceptibility to leprosy (Mira et al. 2004). Functionally, PARK2 is a
ubiquitination E3 ligase that is directly involved in delivery of polyubiquinated proteins to the
proteasome complex, providing a possible connection between antigen presenting cell function
and immune response to M. leprae antigen. Of potential interest too are the genes (CCR6,
GPR31) encoding CC chemokine receptor 6 and the related orphan receptor G protein coupled
receptor 31 at position 167.4 Mb. The CC chemokine CCL20, also known as liver and
activation-regulated chemokine or macrophage inflammatory protein-3 a , is the only chemokine
ligand for CCR6 (reviewed by Schutyser et al. 2003). Ligation of CCL20 to CCR6 is responsible
for chemoattraction of immature dendritic cells, effector and memory T cells to inflammatory
sites, which could thereby contribute to immune response to mycobacterial antigens. DLL1
encoding the Notch ligand delta-1 and PSMB1 encoding the proteasome subunit beta-type 1, both
of which lie at 170.4 Mb, are also important candidate genes in this region. As noted above,
proteasome function is important in degradation of proteins for presentation to T cells by antigen
processing cells. Of potentially greater interest is the recent demonstration (Amsen et al. 2004)
that antigen presenting cells use the Notch pathway to instruct T cell differentiation. In particular,
that Delta family Notch ligands induce T helper 1 cells, while the alternative Jagged family Notch
ligand determines the alternate T helper 2 fate. DLL1 could therefore play a direct role in
determining T helper 1-driven IFN- _ responses to MLSA.
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The 37 families analysed here represent a subset of the families originally collected: in total
92 extended TB families and 72 extended leprosy families were collected, comprising 627 and
372 individuals respectively (Blackwell et al. 1997). Regions that have been highlighted in this
study will therefore be followed up by genotyping in a larger number of families in order to
increase the statistical power to test for linkage, as well as by association analysis in the linked
regions in order to determine variants with potential functional effects contributing to variation in
these traits. Overall, we believe our study has made an important contribution both in terms of
evaluation of genetic statistical methods for analysing this kind of data set for quantitative traits,
and in identifying regions of the genome that may contain genes that contribute to important
immune responses associated with exposure to mycobacterial infections.
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Table 1: List of abbreviations used in this paper
ARMD Age-related macular degeneration
BCG M. bovis bacillus Calmette-Gue´rin
BrUrd Bromodeoxyuridine
cM Centimorgan
ELISA Enzyme-linked immunosorbant assay
gMLSAc Quantitative Trait: Interferon- b release to MLSA corrected for the different measurement methods
gPPDc Quantitative Trait: Interferon- b release to PPD corrected for the different measurement methods
H-E Haseman and Elston
IBD Identical by descent
IFN- b Interferon-gamma
IgGMLSA Quantitative Trait: Antigen-specific IgG to MLSA
IgGMTSA Quantitative Trait: Antigen-specific IgG to MTSA
IgGPPD Quantitative Trait: Antigen-specific IgG to PPD
M. bovis Mycobacterium bovis
M. leprae Mycobacterium leprae
M. tuberculosis Mycobacterium tuberculosis
MLSA M. leprae soluble antigen
MTSA M. tuberculosis soluble antigen
PPD M. tuberculosis purified protein derivative
SI Stimulation index
SIMLSA Quantitative Trait: Antigen-specific lymphocyte proliferation stimulation index to MLSA
SIPPD Quantitative Trait: Antigen-specific lymphocyte proliferation stimulation index to PPD
TB Tuberculosis
TotalIgE Quantitative Trait: Total plasma IgE
V-H Visscher and Hopper
c
H-thymidine Tritiated thymidine
Table 2: Pairwise phenotypic correlation matrix
IgGMLSA IgGMTSA IgGPPD TotalIgE SIMLSA SIPPD gMLSAc gPPDc
IgGMLSA 1.000
IgGMTSA 0.362 1.000
IgGPPD 0.450 0.410 1.000
TotalIgE -0.049 -0.035 0.001 1.000
SIMLSA 0.050 -0.110 -0.129 0.010 1.000
SIPPD 0.029 -0.097 -0.081 0.008 0.599 1.000
gMLSAc 0.040 -0.241 -0.070 0.127 0.271 0.155 1.000
gPPDc -0.062 -0.179 -0.112 0.117 0.208 0.221 0.657 1.000
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Table 4: Permutation test results
Trait Chr Pos Method p-value Perm. p-value Perm. p-value # of perms
(cM) All individuals Within families
TotalIgE 4 175.2 Xu 0.01342 0.01580 0.03140 10000
V-H 0.01586 0.01410 0.02460
H-E 0.00082 0.00050 0.00050
Barber 0.00472 0.01790 0.00340
Holmans 0.00015 0.00170 0.00200
TotalIgE 9 158.2 Xu 0.17372 0.15520 0.13710 10000
V-H 0.18870 0.16320 0.14870
H-E 0.04881 0.04600 0.02410
Barber 0.00715 0.01670 0.00550
Holmans 0.00021 0.00090 0.00420
SIPPD 1 160.7 Xu 0.00343 0.00951 0.00166 100000
V-H 0.00296 0.00913 0.00171
H-E 0.00276 0.00267 0.00069
Barber 0.00049 0.00519 0.00119
Holmans 0.00002 0.00035 0.00043
gMLSAc 4 189.5 Xu 0.33161 0.37700 0.35900 1000
V-H 0.33242 0.37700 0.36100
H-E 0.35289 0.39200 0.47300
Barber 0.00179 0.09200 0.02000
Holmans 0.47669 0.48600 0.56700
gPPDc 1 203.3 Xu 9.33e-07 0.00031 0.00013 300000
V-H 1.21e-06 0.00032 0.00012
H-E 0.00016 0.00039 0.00016
Barber 0.00110 0.02696 0.01629
Holmans 0.01229 0.01723 0.12744
gPPDc 18 17.7 Xu 0.12077 0.14775 0.12465 100000
V-H 0.12048 0.14749 0.12175
H-E 0.03660 0.03358 0.01534
Barber 0.02554 0.06324 0.02540
Holmans 0.00002 0.00077 0.00233
Table 5: Comparison of results for the traditional H-E method from STATA, XWXW,
GENEHUNTER and S.A.G.E. programs, using simplified test data sets
Method Coefficient (beta) Test statistic f value
Test data set 1
STATA - No robust variance -21.0562 (t) -2.754 0.00503
STATA - Robust variance (scaled) -21.0562 (t) -2.172 0.01908
XWXW 21.0562 (z) 2.172 0.01493
GENEHUNTER -21.0562 (t) 2.851 0.00398
S.A.G.E. - No robust variance 21.0562 (t) 2.754 0.00503
S.A.G.E. - Robust variance 21.0562 (t) 2.172 0.01908
0.01493 (using normal approx.)
Test data set 2
STATA - No robust variance -12.3306 (t) -2.598 0.00540
STATA - Robust variance (scaled) -12.3306 (t) -2.154 0.01683
XWXW 12.3306 (z) 2.154 0.01562
GENEHUNTER -12.3306 (t) 2.625 0.00502
S.A.G.E. - No robust variance 12.3306 (t) 2.598 0.00540
S.A.G.E. - Robust variance 12.3306 (t) 2.154 0.01683
0.01562 (using normal approx.)
Table 6: Comparison of results from STATA, XWXW and S.A.G.E for the Xu et al. (2000) (unified
Haseman-Elston) method
Method Test statistic p-value
Test data set 1
STATA - Robust variance (scaled) (t) 2.244 0.01240
XWXW (z) 2.301 0.01070
S.A.G.E - Robust variance, Identity matrix (t) 2.399 0.01155
0.00822 (using normal approx.)
Test data set 2
STATA - Robust variance (scaled) (t) 3.654 0.00013
XWXW (z) 3.624 0.00015
S.A.G.E - Robust variance, Identity matrix (t) 3.505 0.00034
0.00023 (using normal approx.)
Figure Legend
Figure 1: Q-Q plot showing quantiles of log transformed traits against quantiles of standard Normal
distribution. Departure from normality at the tails of the distribution is indicated for several traits
by departure from the linear relationship.
Figure 2: Results from variance components analysis for the eight quantitative traits.
Figure 3: Results from original Haseman-Elston (H-E) and Visscher-Hopper (V-H) analysis
Figure 4: Results from Merlin-Regress analysis
Figure 5: Example of six traits/regions where the regression methods varied in significance.
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